U.S. FDA Accepts New Drug Application and Grants Priority Review for Darolutamide

WHIPPANY, N.J., April 29, 2019 /PRNewswire/ -- Bayer today announced the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review to darolutamide for the treatment of non-metastatic...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news